Regenicin, Inc. – OTC:RGIN
Regenicin stock price today
Regenicin stock price monthly change
Regenicin stock price quarterly change
Regenicin stock price yearly change
Regenicin key metrics
Market Cap | 214.87K |
Enterprise value | N/A |
P/E | -0.15 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | -39.18 |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeRegenicin stock price history
Regenicin stock forecast
Regenicin financial statements
| Dec 2022 | 0 | -295.85K | |
|---|---|---|---|
| Mar 2023 | 0 | -300.47K | |
| Jun 2023 | 0 | 0 | |
| Sep 2023 | 0 | 0 |
| Dec 2022 | 11794326 | 17.66M | 149.81% |
|---|---|---|---|
| Mar 2023 | 11859194 | 18.07M | 152.37% |
| Jun 2023 | 0 | 0 | |
| Sep 2023 | 0 | 0 |
| Dec 2022 | -361.79K | 0 | 12.14M |
|---|---|---|---|
| Mar 2023 | -328.28K | 0 | -13.11M |
| Jun 2023 | 0 | 0 | 0 |
| Sep 2023 | 0 | 0 | 0 |
Regenicin alternative data
| Aug 2023 | 3 |
|---|---|
| Sep 2023 | 3 |
| Oct 2023 | 3 |
| Nov 2023 | 3 |
| Dec 2023 | 3 |
| Jan 2024 | 3 |
| Feb 2024 | 3 |
| Apr 2024 | 3 |
| May 2024 | 3 |
| Jun 2024 | 3 |
| Jul 2024 | 3 |
Regenicin other data
| Insider | Compensation |
|---|---|
Mr. Randall E. McCoy (1949) Chairman, Chief Executive Officer & Pres | $250,000 |
Dr. J. Roy Nelson (1948) Chief Science Officer | $150,000 |
Mr. John J. Weber (1950) Chief Financial Officer & Director | $125,000 |
-
What's the price of Regenicin stock today?
One share of Regenicin stock can currently be purchased for approximately $0.
-
When is Regenicin's next earnings date?
Unfortunately, Regenicin's (RGIN) next earnings date is currently unknown.
-
Does Regenicin pay dividends?
No, Regenicin does not pay dividends.
-
How much money does Regenicin make?
Regenicin has a market capitalization of 214.87K.
-
What is Regenicin's stock symbol?
Regenicin, Inc. is traded on the OTC under the ticker symbol "RGIN".
-
What is Regenicin's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Regenicin?
Shares of Regenicin can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Regenicin's key executives?
Regenicin's management team includes the following people:
- Mr. Randall E. McCoy Chairman, Chief Executive Officer & Pres(age: 76, pay: $250,000)
- Dr. J. Roy Nelson Chief Science Officer(age: 77, pay: $150,000)
- Mr. John J. Weber Chief Financial Officer & Director(age: 75, pay: $125,000)
-
How many employees does Regenicin have?
As Jul 2024, Regenicin employs 3 workers.
-
When Regenicin went public?
Regenicin, Inc. is publicly traded company for more then 15 years since IPO on 16 Nov 2009.
-
What is Regenicin's official website?
The official website for Regenicin is regenicin.com.
-
Where are Regenicin's headquarters?
Regenicin is headquartered at 10 High Court, Little Falls, NJ.
-
How can i contact Regenicin?
Regenicin's mailing address is 10 High Court, Little Falls, NJ and company can be reached via phone at +973 5578914.
Regenicin company profile:
Regenicin, Inc.
regenicin.comOTC
3
Biotechnology
Healthcare
Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.
Little Falls, NJ 07424
CIK: 0001412659
ISIN: US75887Q1022
CUSIP: 75887Q102
